Oral drug delivery system
Details for Australian Patent Application No. 2004283565 (hide)
International Classifications
Event Publications
13 April 2006 PCT application entered the National Phase
PCT publication WO2005/039481 Priority application(s): WO2005/039481
10 August 2006 Assignment before Grant
Sun Pharmaceuticals Industries Limited; Dharmadhikari, Nitan; Zala, Yashoraj; Singh, Amarjit The application has been assigned to Sun Pharmaceuticals Industries Limited
21 September 2006 Change of Name(s) of Applicant(s), Section 104
Sun Pharmaceuticals Industries Limited The name of the applicant has been changed to Sun Pharmaceutical Industries Limited
26 February 2009 Assignment before Grant
Sun Pharmaceutical Industries Limited The application has been assigned to Sun Pharma Advanced Research Company Limited
17 March 2011 Application Accepted
Published as AU-B-2004283565
7 July 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 05 May 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
27 October 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 05 May 2011
3 November 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004283609-Fibroblast-mobilizing agent containing G-CSF and wound remedy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser